The very first long-form report that Exits & Outcomes published was called Approximating Livongo Health's S-1. That was in May 2019. Almost a year later I wrote a similar report about Livongo's biggest rival at the time -- Omada Health. I fully
>
21 min. Read
11.22.24
Approximating Omada Health’s S-1 Before Its 2025 IPO
In this article:
This 5,500-word report includes estimates for Omada Health’s annual revenues (2015-2024), reveals some of its pricing, tracks its customer growth, details its annual net new participants, and examines how GLP-1s have likely driven significant growth for the company in 2024. Plus: Other considerations as an IPO likely nears in 2025.
×
![]()
